Global Wound Care Biologics Market is Size, Trends, and Growth Opportunity, By Product (Biological Skin Substitutes and Topical Agents), Wound Type (Ulcers, Surgical and Traumatic Wounds and Burns), End User (Hospitals/Clinics, Ambulatory Surgical Centers and Other End Users), By Region and Forecast to 2030.

Global Wound Care Biologics Market

The Global Wound Care Biologics Market was valued at USD 1.77 billion in 2022 and is expected to reach USD 4.00 billion by 2030, at a CAGR 9.82 % during the forecast period 2023- 2030.
Several intracellular, extracellular, and intercellular processes, including collagen coagulation and deposition, epithelialization, fibrous tissue accretion, wound contraction, inflammatory events, tissue granulation, and remodeling, are coordinated and activated during the complex process of wound healing. Bioengineered products called wound care biologics are used to treat non-healing lower extremity wounds.
Market Drivers
The global market is being driven by an increase in the number of diseases and conditions that affect the ability of wounds to heal. The aging of the global population, an increase in accidents and operations, and an increase in the incidence of diseases like diabetes are just a few of the many variables that have contributed to the remarkable rise in chronic and surgical wounds during the past ten years. Diabetes can increase the occurrence and severity of wound infections, ulcerations (such as leg or foot ulcers), and chronic wounds, all of which necessitate intensive medical attention and result in high medical costs. By giving the host's epithelial cells a prepared collagen matrix, receptors, and bound growth factors, it helps them move to and colonize the wound site.
Market Restraints
The high cost of wound care biologics and wound treatment will restrain market expansion. The potential of skin substitute failure is anticipated to present a challenge to the wound care biologics industry throughout the forecast period.
COVID-19 Impact
The COVID-19 outbreak is being addressed by pharmaceutical and biotech businesses cooperating with governments all over the world on everything from vaccine development to issues with the medication supply chain. There are now 155 compounds and about 115 vaccine candidates in the R&D pipeline. Also, there has been a sharp rise in demand for routinely used medications like hydroxychloroquine for COVID-19 therapy. Because of the rising demand for COVID-19 vaccines and treatment medications, the pharmaceutical and biotechnology sectors are predicted to expand dramatically in the next years.

Market Segmentation

Global Wound Care Biologics Market is segmented into Product, Wound Type, and End User.
Based on Product, the market is divided into Biological Skin Substitutes and Topical Agents.
Based on Wound Type, the market is divided into Ulcers, Surgical and Traumatic Wounds, and Burns.
Based on End Users, the market is Hospitals/Clinics, Ambulatory Surgical Centers, and Other End Users.

Regional Analysis

The Global Wound Care Biologics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
The market for wound care biologics is dominated by North America, which is anticipated to expand throughout the forecast period. One of the main drivers of the industry's expansion is an increase in the prevalence of chronic wounds among diabetic patients. Better wound care is also influenced by growing disposable money and living standards. The rising incidence of lifestyle-related illnesses such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers is another factor anticipated to influence the growth of the advanced wound care management market during the coming years.

Key Players

Various key players are discussed in the Global Wound Care Biologics Market Report including: BASF SE, Cargill, Incorporated, Evonik Industries AG, DSM, and Lonza.

Market Taxonomy

By Product 

• Biological Skin Substitutes 
• Topical Agents

By Wound Type

• Ulcers
• Surgical
• Traumatic Wounds
• Burns

By End User 

• Hospitals/Clinics
• Ambulatory Surgical Centers
• Other End Users
By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Global Wound Care Biologics Market 
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Wound Care Biologics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn 
4.2.6 Post covid-19 world Supply & Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Wound Care Biologics Market, By Product  
5.1 Y-o-Y Growth Comparison, By Product  
5.2 Global Wound Care Biologics Market Share Analysis, By Product  
5.3 Global Wound Care Biologics Market Size and Forecast, By Product 
5.3.1 Biological Skin Substitutes 
5.3.2 Topical Agents
6 Global Wound Care Biologics Market, By Wound Type
6.1 Y-o-Y Growth Comparison, By Wound Type
6.2 Global Wound Care Biologics Market Share Analysis, By Wound Type
6.3 Global Wound Care Biologics Market Size and Forecast, By Wound Type
6.3.1 Ulcers
6.3.2 Surgical
6.3.3 Traumatic Wounds and Burns
7 Global Wound Care Biologics Market, By End User
7.1 Y-o-Y Growth Comparison, By End User 
7.2 Global Wound Care Biologics Market Share Analysis, By End User 
7.3 Global Wound Care Biologics Market Size and Forecast, By End User 
7.3.1 Hospitals/Clinics
7.3.2 Ambulatory Surgical Centers
7.3.3 Other End Users
8 Global Wound Care Biologics Market, By Region
8.1 Global Wound Care Biologics Market Share Analysis, By Region
8.2 Global Wound Care Biologics Market Size and Forecast, By Region
9 North America Wound Care Biologics Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Wound Care Biologics Market Share Analysis, By Product  
9.3 North America Wound Care Biologics Market Size and Forecast, By Wound Type
9.4 North America Wound Care Biologics Market Size and Forecast, By End User 
9.5 North America Wound Care Biologics Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Wound Care Biologics Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Wound Care Biologics Market Share Analysis, By Product  
10.3 Europe Wound Care Biologics Market Size and Forecast, By Wound Type
10.4 Europe Wound Care Biologics Market Size and Forecast, By End User 
10.5 Europe Wound Care Biologics Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Wound Care Biologics Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Wound Care Biologics Market Share Analysis, By Product  
11.3 Asia Pacific Wound Care Biologics Market Size and Forecast, By Wound Type
11.4 Asia Pacific Wound Care Biologics Market Size and Forecast, By End User 
11.5 Asia Pacific Wound Care Biologics Market Size and Forecast, By Country
11.5.1 China 
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Wound Care Biologics Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Wound Care Biologics Market Share Analysis, By Product  
12.3 Latin America Wound Care Biologics Market Size and Forecast, By Wound Type
12.4 Latin America Wound Care Biologics Market Size and Forecast, By End User 
12.5 Latin America Wound Care Biologics Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Wound Care Biologics Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Wound Care Biologics Market Share Analysis, By Product  
13.3 Middle East Wound Care Biologics Market Size and Forecast, By Wound Type
13.4 Middle East Wound Care Biologics Market Size and Forecast, By End User 
13.5 Middle East Wound Care Biologics Market Size and Forecast, By Country
13.6.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 BASF SE

15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Cargill
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Incorporated
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Evonik Industries AG
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 DSM
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Lonza
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies